Supplements · Sweeteners · Diets · Metabolic & Cardiometabolic
allulose increases GLP-1
In plain terms: Does the rare sugar allulose boost the appetite-suppressing gut hormone GLP-1?
Part of: 🧪 allulose
Yes, but mostly shown in mice; a clean human trial didn't see a reliable effect yet.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Human trials (RCT / n-of-1)
How the studies fall
What the evidence shows
Allulose (D-psicose) acutely increases GLP-1 secretion. A high-quality human RCT (Wölnerhanssen 2022, J Nutr, PMID 35135006) found an oral allulose bolus induced a significant plasma GLP-1 release vs control (P_Holm<0.0001, large effect d_z>1), corroborated by consistent rodent data and enteroendocrine-cell mechanism. The acute incretin effect is real and established.
The evidence (14)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Iba 2026 · Int J Molecular Sciences | animal | supports | moderate | D-allulose-induced GLP-1 release ameliorated sucrose-induced obesity and glucose intolerance in ovariectomized mice. |
| Mizuma 2025 · Endocrinology | animal | supports | moderate | Luminal D-allulose promoted GLP-1 secretion partly via intestinal distension in rats, a non-metabolic route to incretin release. |
| Wolnerhanssen BK, et al. 2022 · J Nutr | RCT | supports | high | human RCT n=18 DB 25g intragastric D-allulose raised GLP-1/CCK/PYY vs water P<.0001 dz>1; independent |
| Iwasaki 2018 · Nat Commun | animal | supports | high | [FT-verified] oral D-allulose induces GLP-1 via vagal afferents. ANIMAL/MECHANISM-ONLY mouse |
| Noh 2026 · Nutrients | RCT | supports | low | [FT-verified] human RCT n=10 allulose+meal raised GLP-1 tAUC +12% p=.042 lower glucose/insulin; Samyang COI; not null |
| Deemer 2020 · Nutrition Research | mechanism | mixed | low | Review notes non-metabolizable sweeteners and ketones modulate gut satiety hormones; context for allulose acting via gut sweet-taste/GLP-1 pathway. |
| Hayakawa 2018 · Biochem Biophys Res Commun | animal | supports | moderate | [FT-verified] luminal allulose stimulates GLP-1 not GIP. ANIMAL rat |
| Masuda Y et al 2025 · study_type: animal | animal | supports | moderate | Male mice given single peroral doses of ketohexoses (1-3 g/kg); D-allulose, D-tagatose, D-sorbose (but not aldohexoses) significantly raised plasma GLP-1 and suppressed food intake in a GLP-1-receptor-antagonist-reversible manner. |
| Busch 2026 · JMIR Research Protocols | observational | tested-null | low | Registered human crossover protocol testing allulose vs aspartame on postprandial GLP-1; design-stage, cites prior human/animal GLP-1 signal as preliminary. |
| Medak 2023 · Frontiers in Pharmacology | animal | supports | low | Raising endogenous GLP-1 (a pathway allulose engages) dampened acute metabolic perturbations, indirect support for the incretin mechanism. |
| Yermek 2022 · Biochem Biophys Res Commun | animal | supports | moderate | Central D-allulose cooperated with GLP-1 to activate arcuate POMC neurons, mechanistically linking allulose to GLP-1-mediated appetite/energy control. |
| Suzuki T et al 2022 · study_type: animal | animal | supports | low | Rat intestinal perfusion + mouse study; allulose ingestion after TPN paralleled GLP-2 (and monitored GLP-1) secretion in TPN rats and normal mice, alongside gut mucosal transcriptome changes. |
| Cayabyab 2024 · Nutrients | animal | supports | moderate | 12-week allulose-rich diet in diet-induced-obese/T2D rats lowered glucose and was associated with enhanced incretin/GLP-1 signaling. |
| Lee 2025 · Antioxidants Redox Signaling | in-vitro | supports | moderate | D-allulose modulated the GLP-1 receptor pathway via ER-stress mechanisms to regulate obesity in cellular/animal models. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.